๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Cancer
Clinical trial register · Australia

Cancer Trials in Australia, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 3331 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:46 UTC
3331
Studies in scope
all four open statuses
1807
Recruiting now
open to new participants
758
Lead sponsors
across recruiting studies
Top sites
Melbourne 5 South Brisbane 3 Darlinghurst 3 Nedlands 2 Sydney 2
Narrow the registerReset
Recruitment status
Phase
Site location
Melbourne5 South Brisbane3 Darlinghurst3 Nedlands2 Sydney2
All 27 locations
Target enrolment
to

Cancer trials in Australia

17 of 3331 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Not yet open
A Master Trial Assessing the Technical Feasibility of First-In-Human Real-Time Image Guided Radiation Therapy Methods
NCT06708221Cancer
University of Sydney
Not applicable
40
Melbourne
2027-06
Active, closed
EQUIP - Evaluation of Quality of Imaging on a Next-generation Total Body Pet Scan in Comparison to Conventional PET
NCT07263815Cancer
Peter MacCallum Cancer Centre, Australia
Not applicable
25
Melbourne
2025-11-24
Recruiting
Wearable Technology and Machine Learning for Early Detection and Risk Assessment of Unacceptable Toxicities in a Paediatric Oncology Cohort
NCT07030998Cancer, Infection, Digital Health, Wearable Devices
Murdoch Childrens Research Institute
Observational
150
Parkville
2025-10-15
Recruiting
Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
NCT07072728Adjustment Disorder, Adjustment Disorder With Anxious Mood, Cancer, Cancer Cachexia
Psyence Australia Pty Ltd
Phase 2
87
Abbotsford, Northcote, Leederville
2025-10-01
Recruiting
Study of IMC-P115C in Advanced PRAME-Positive Cancers
NCT07156136PRAME Positive, Cancer, HLA-A*02:01-positive
Immunocore Ltd
Phase 1
140
Adelaide, Nedlands, Wollstonecraft
2024-11-07
Active, closed
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors
NCT06533059Cancer, Breast Cancer, Endometrial Cancer, Metastatic Cancer
Alterome Therapeutics, Inc.
Phase 1
110
Randwick, Malvern, Nedlands
2024-08-22
Recruiting
Phase 1/2 Study of IMC-R117C in Selected Advanced Cancers
NCT06840119Cancer, HLA-A*02:01-positive
Immunocore Ltd
Phase 1/2
600
Darlinghurst, Melbourne
2024-01-10
Recruiting
FOG-001 in Locally Advanced or Metastatic Solid Tumors
NCT05919264Cancer, Colorectal Cancer, Solid Tumor, Locally Advanced Solid Tumor
Parabilis Medicines, Inc.
Phase 1/2
619
South Brisbane, Melbourne
2023-05-23
By invitation
Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Durvalumab
NCT05303532Cancer
AstraZeneca
Phase 3
214
Box Hill, Melbourne
2022-04-19
Recruiting
Cancer Predisposition Testing by Family-based Whole-genome Sequencing (WGS) in Every Child With Newly Diagnosed Cancer
NCT04903782Neoplastic Syndromes, Hereditary, Cancer, Genetic Predisposition to Disease
Sydney Children's Hospitals Network
Observational
270
Newcastle, Sydney
2021-03-08
Active, closed
Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma
NCT04300244Cancer, Cancer, Lung, Cancer of Lung, Mesothelioma
ร…slaug Helland
Phase 2
118
Perth
2020-05-04
Active, closed
ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors
NCT04205227Cancer, Melanoma, Ovary Cancer, Pancreatic Cancer
ENB Therapeutics, Inc
Phase 1/2
137
Albury, Blacktown, Darlinghurst
2020-02-18
Recruiting
Pan Tumor Rollover Study
NCT03899155Cancer
Bristol-Myers Squibb
Phase 2
1,500
Coffs Harbour, North Sydney, Sydney, Waratah, Westmead, Greenslopes, South Brisbane, Southport
2019-08-09
Active, closed
A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors
NCT03893955Cancer, Advanced Solid Tumors, Triple-Negative Breast Cancer (TNBC), Non-small-cell-lung-cancer (NSCLC)
AbbVie
Phase 1
150
South Brisbane
2019-05-21
Rows per page Showing 1–17 of 17
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-australia/condition/cancer

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,331 studies in total at the last sync on 26 Sep 2026, 19:46 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 17 of those studies listing the condition Cancer.

How many Cancer trials are recruiting in Australia?

7 of the 17 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:46 UTC sync. A further 1 have not yet opened recruitment, 8 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Cancer), 17 studies
PhaseStudiesRecruitingShare
Phase 34023.5%
Phase 13117.6%
Phase 1/23217.6%
Phase 23217.6%
Not applicable2011.8%
Observational2211.8%

Most active sponsors

Lead sponsors with the most studies (Cancer)
Lead sponsorStudiesRecruiting
Hoffmann-La Roche20
Immunocore Ltd22
AbbVie10
Alterome Therapeutics, Inc.10
AstraZeneca10
Bayer10
Bristol-Myers Squibb11
ENB Therapeutics, Inc10
Murdoch Childrens Research Institute11
Parabilis Medicines, Inc.11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.